Avalo Therapeutics
AVTX
AVTX
97 hedge funds and large institutions have $464M invested in Avalo Therapeutics in 2026 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 30 increasing their positions, 20 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
26.83% more ownership
Funds ownership: 109.66% → 136.49% (+27%)
15% more funds holding
Funds holding: 84 → 97 (+13)
Holders
97
Holding in Top 10
1
Calls
$43M
Puts
$5.7M
Top Buyers
| 1 | +$41.6M | |
| 2 | +$33.8M | |
| 3 | +$22M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$14.3M |
| 5 |
RI
RTW Investments
New York
|
+$13.4M |
Top Sellers
| 1 | -$11.1M | |
| 2 | -$9.52M | |
| 3 | -$5.92M | |
| 4 |
PSC
Patient Square Capital
Menlo Park,
California
|
-$5.67M |
| 5 |
JG
Jain Global
New York
|
-$3.95M |
